Amino Acids

, Volume 38, Issue 1, pp 271–278 | Cite as

Prevention of hypercholesterolemia and atherosclerosis in the hyperlipidemia- and atherosclerosis-prone Japanese (LAP) quail by taurine supplementation

  • Shigeru MurakamiEmail author
  • T. Sakurai
  • H. Tomoike
  • M. Sakono
  • T. Nasu
  • N. Fukuda
Original Article


The effects of taurine supplementation on the serum cholesterol levels and the progression of atherosclerosis were investigated in the hyperlipidemia- and atherosclerosis-prone Japanese (LAP) quail. The ingestion of a high-cholesterol diet containing 1% cholesterol by LAP quails for 60 days resulted in a marked elevation in serum non-HDL cholesterol and triglyceride, as well as severe aortic lesions with lipid droplets. An immunohistochemical study showed that the lesion consisted of mainly lipid-rich macrophages and T cells. Sixty-day taurine supplementation (1% in drinking tap water) to LAP quails fed high-cholesterol diet containing 1% cholesterol significantly reduced serum non-HDL cholesterol from 4,549 to 2,350 mg/dl. The serum triglyceride level also decreased after taurine supplementation from 703 to 392 mg/dl. Although the HDL cholesterol level significantly decreased due to the high-cholesterol diet, it recovered to the control level fed a regular diet in response to taurine. Bile acid production was stimulated and hepatic cholesterol was reduced by taurine supplementation. A quantitative analysis using aortic cross-sections showed that areas of oil-red O positive lipid accumulation significantly decreased by 74% after taurine supplementation. These results demonstrated the lipid-lowering and anti-atherosclerotic effects of taurine in a diet-induced hyperlipidemic LAP quail model. The prevention of atherosclerosis by taurine is mainly attributed to an improvement in the serum cholesterol and triglyceride levels, which may be related to changes in the hepatic cholesterol metabolism.


Taurine LAP quail Atherosclerosis Hypercholesterolemia 


  1. Casale EN, Qureshi MA, Shih JCH (1992) Immunocytochemical and scanning electron microscopic studies of atherosclerosis in Japanese quail. Poult Sci 71:141–150PubMedGoogle Scholar
  2. Fann JI, Angell SK, Cahill PD, Kosek JC, Miller DC (1989) Effects of fish oil on arteriosclerosis in the Japanese quail. Cardiovasc Res 23:631–638CrossRefPubMedGoogle Scholar
  3. Folch J, Lees M, Sloane-Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497–509PubMedGoogle Scholar
  4. Huxtable RJ (1992) Physiological actions of taurine. Physiol Rev 72:101–163PubMedGoogle Scholar
  5. Ide T, Horii M (1987) A simple method for the extraction and determination of non-conjugated and conjugated luminal bile acids in rats. Agric Biol Chem 51:3155–3157Google Scholar
  6. Inoue Y, Toda T, Igawa T, Tani T, Kimura Y (1995) The response of serum and hepatic lipids and the aortic wall to different levels of dietary cholesterol: a comparative study between hyperlipidemia-and-atherosclerosis-prone quail and commercially available quail. Tohoku J Exp Med 175:1–13CrossRefPubMedGoogle Scholar
  7. Ito T, Tsukada T, Ueda M, Wanibuchi H, Shiomi M (1994) Immunohistochemical and quantitative analysis of cellular and extracellular components of aortic atherosclerosis in WHHL rabbits. J Atheroscler Thromb 1:45–52PubMedGoogle Scholar
  8. Iwasaki H, Oku H, Toda T, Nasu T, Miyagi T, Chinen I (2000) Increased cholesterol absorption by hyperlipidemia atherosclerosis prone (LAP) Japanese quail. J Nutr Sci Vitaminol 46:235–239PubMedGoogle Scholar
  9. Kondo Y, Toda Y, Kitajima H, Oda H, Nagate T, Kameo K, Murakami S (2001) Taurine inhibits development of atherosclerotic lesions in apolipoprotein E-deficient mice. Clin Exp Pharmacol Physiol 28:809–815CrossRefPubMedGoogle Scholar
  10. Matsushima Y, Sekine T, Kondo Y, Sakurai T, Kameo K, Tachibana M, Murakami S (2001) Effects of taurine on serum cholesterol levels and development of atherosclerosis in spontaneously hyperlipidemic (SHL) mice. Clin Exp Pharmacol Physiol 30:295–299CrossRefGoogle Scholar
  11. Mizushima S, Moriguchi EH, Ishikawa P, Hekman P, Nara Y, Miura G, Moriguchi Y, Yamori Y (1997) Fish intake and cardiovascular risk among middle-aged Japanese in Japan and Brazil. J Cardiovasc Risk 4:191–199CrossRefPubMedGoogle Scholar
  12. Murakami S, Yamagishi I, Asami Y, Ohta Y, Toda Y, Nara Y, Yamori Y (1996) Hypolipidemic effect of taurine in stroke-prone spontaneously hypertensive rats. Pharmacology 52:303–313CrossRefPubMedGoogle Scholar
  13. Murakami S, Kondo-Ohta Y, Tomisawa K (1999) Improvement in cholesterol metabolism in mice given chronic treatment of taurine and fed a high-fat diet. Life Sci 64:83–91CrossRefPubMedGoogle Scholar
  14. Murakami S, Kondo Y, Sakurai T, Kitajima H, Nagate T (2002) Taurine suppresses development of atherosclerosis in Watanabe heritable hyperlipidemic (WHHL) rabbits. Atherosclerosis 163:79–87CrossRefPubMedGoogle Scholar
  15. Nagata J, Oku H, Toda T, Chinen I (1996) Effect of dietary cholesterol on the activities of key enzymes of cholesterol metabolism in hyperlipidemia- and atherosclerosis-prone Japanese quail. J Nutr Sci Vitaminol 42:287–300PubMedGoogle Scholar
  16. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14:133–140PubMedGoogle Scholar
  17. Ojerio AD, Pucak GJ, Clarkson TB, Bullock BC (1972) Diet-induced atherosclerosis and myocardial infarction in Japanese quail. Lab Anim Sci 22:33–39PubMedGoogle Scholar
  18. Petty MA, Kintz J, DiFrancesco GF (1990) The effects of taurine on atherosclerosis development in cholesterol-fed rabbits. Eur J Pharmacol 180:119–127CrossRefPubMedGoogle Scholar
  19. Radcliffe JD, Liebsch KS (1985) Dietary induction of hypercholesterolemia and atherosclerosis in Japanese quail of strain SEA. J Nutr 115:1154–1161PubMedGoogle Scholar
  20. Schulze PC, Lee RT (2005) Oxidative stress and atherosclerosis. Curr Atheroscler Rep 7:242–248CrossRefPubMedGoogle Scholar
  21. Shih JC, Pullman EP, Kao KJ (1983) Genetic selection, general characterization, and histology of atherosclerosis-susceptible and resistant quail. Atherosclerosis 49:41–53CrossRefPubMedGoogle Scholar
  22. Suckling KE, Stange EF (1985) Role of acyl-CoA:cholesterol acyltransferase in cellular cholesterol metabolism. J Lipid Res 26:647–671PubMedGoogle Scholar
  23. Yamamoto K, Yoshitani A, Sakono M, Nasu T, Murakami S, Fukuda N (2000) Dietary taurine decreases hepatic secretion of cholesterol ester in rats fed a high-cholesterol diet. Pharmacology 60:27–33 CrossRefPubMedGoogle Scholar
  24. Yamori Y, Nara Y, Ikeda K, Mizushima S (1996) Is taurine a preventive nutritional factor of cardiovascular diseases or just a biological marker of nutrition? Adv Exp Med Biol 403:623–629PubMedGoogle Scholar
  25. Yamori Y, Liu L, Ikeda K, Miura A, Mizushima S, Miki T, Nara Y (2001) Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study. Hypertens Res 24:453–457CrossRefPubMedGoogle Scholar
  26. Yokogoshi H, Mochizuki H, Nanami K, Hida Y, Miyachi F, Oda H (1999) Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. J Nutr 129:1705–1712PubMedGoogle Scholar
  27. Zhang M, Bi LF, Fang JH, Su XL, Da GL, Kuwamori T, Kagamimori S (2004) Beneficial effects of taurine on serum lipids in overweight or obese non-diabetic subjects. Amino Acids 26:267–271PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Shigeru Murakami
    • 1
    • 4
    Email author
  • T. Sakurai
    • 1
  • H. Tomoike
    • 1
  • M. Sakono
    • 2
  • T. Nasu
    • 3
  • N. Fukuda
    • 2
  1. 1.Medicinal Research LaboratoriesTaisho Pharmaceutical Co. LtdSaitamaJapan
  2. 2.Department of Biochemistry and Applied Biosciences, Faculty of AgricultureMiyazaki UniversityMiyazakiJapan
  3. 3.Department of Veterinary Medicine, Faculty of AgricultureMiyazaki UniversityMiyazakiJapan
  4. 4.R&D Headquarters, Self Medication BusinessTaisho Pharmaceutical Co. LtdTokyoJapan

Personalised recommendations